ArticleClinical cancer research : an official journal of the American Association for Cancer Research2008

A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.

Archie N Tse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.